PMID: 9187534Feb 1, 1997Paper

Potent and selective aromatase inhibitor: in vitro and in vivo studies with s-triazine derivative SEF19

Endocrine Research
M TakahashiS Kawashima

Abstract

We found a potent aromatase inhibitor through the screening of agents for estrogen-dependent breast cancer. SEF19 (2-(imidazol-1-yl)-4,6-dimorphorino-1,3,5-triazine) decreased 50% of human placental aromatase activity in vitro at the concentration of 5.3 nM. In order to clarify the selectivity of SEF19 for enzyme inhibition, we determined the effect of SEF19 on the activities of four steroidogenic cytochrome P450 enzymes in porcine adrenal gland, P450SCC(side-chain cleavage of cholesterol), P450(11 beta) (11 beta-hydroxylase), P450(17 alpha)(17 alpha-hydroxylase/C17,20 lyase) and P450C21 (21-hydroxylase). SEF19 failed to inhibit the activities of porcine adrenal P450SCC, P450(17 alpha) and P450C21 up to the concentration of 100 microM and showed some inhibition on P450(11 beta) activity at 100 microM, while SEF19 completely nullified the aromatase activity at 1 microM. We also determined the potency of SEF19 for the suppression of aromatase activity in vivo. SEF19 suppressed dose-dependently the uterine hypertrophy of immature rats caused by administration of androstenedione (30 mg/kg, s.c.). The ED50 of SEF19 for the suppression of uterine hypertrophy was 0.8 mumol/kg. These results suggest that SEF19 may serve as a potent and...Continue Reading

References

Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J I RaatsH C Falkson
Jan 1, 1990·Journal of Enzyme Inhibition·A S BhatnagarK Schieweck
Mar 15, 1990·Cancer·A LiptonR J Santen
Jan 1, 1989·The Journal of Clinical Endocrinology and Metabolism·R J SantenA Lipton
Oct 1, 1989·The Journal of Clinical Endocrinology and Metabolism·S W LambertsF H De Jong
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·D CunninghamR C Coombes
Jan 29, 1986·Biochemical and Biophysical Research Communications·S NakajinP F Hall
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M Shikita, P F Hall
Apr 1, 1967·The Journal of Clinical Endocrinology and Metabolism·R N DexterG W Liddle
Apr 1, 1968·Proceedings of the Society for Experimental Biology and Medicine·M P Cohen
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M DowsettI E Smith
Jun 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·A M Brodie
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·K SchieweckM Lang
Dec 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·Y ShizutaS Ulick

❮ Previous
Next ❯

Citations

Oct 21, 1999·The Journal of Steroid Biochemistry and Molecular Biology·P AuvrayS Rault

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosynthetic Transformations

Biosyntheic transformtions are multi-step, enzyme-catalyzed processes where substrates are converted into more complex products in living organisms. Simple compounds are modified, converted into other compounds, or joined together to form macromolecules. Discover the latest research on biosynthetic transformations here.